Company Filing History:
Years Active: 1997-2002
Title: Gianfranco Pancino: Innovator in Feline Immunodeficiency Research
Introduction
Gianfranco Pancino is a notable inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the study of feline immunodeficiency virus (FIV). His work has led to the development of innovative peptides that have potential applications in the prevention and treatment of this viral infection in cats.
Latest Patents
Gianfranco Pancino holds 4 patents, with his latest invention focusing on peptides derived from the ENV gene of the feline immunodeficiency virus. This invention is centered around peptides encoded by the FIV env gene and their immunoprophylactic applications. The peptides are capable of inducing a certain degree of protection against FIV infection and are selected from a specific group of sequences. These peptides contain 12 to 19 amino acids, including a notable sequence: Lys-Lys-Gly-Leu-Gln-Gln-Leu-Gln-Glu-Trp-Glu-Asp-Trp-Val-Gly-Trp-Ile-Gly-Asn (SEQ ID NO:1). Additionally, the invention includes mutated proteins encoded by a lentivirus mutated env gene.
Career Highlights
Gianfranco Pancino is affiliated with the Centre National De La Recherche Scientifique, a prestigious research institution in France. His work has been instrumental in advancing the understanding of feline immunodeficiency and developing potential therapeutic solutions.
Collaborations
Some of his notable coworkers include Pierre Sonigo and Alexandre Avrameas, who have collaborated with him on various research projects.
Conclusion
Gianfranco Pancino's innovative research and patents in the field of feline immunodeficiency virus highlight his significant contributions to veterinary medicine. His work continues to pave the way for advancements in immunoprophylactic treatments for this viral infection.